Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Can NervGen keep a lid on explosive news?

Speculation of early “evidence” of successful proof-of-concept human trials sparks stock rallies Trial volunteers taking a placebo are offered the real deal in a follow-up trial as a “reward” The company&Clo...
Knox Henderson | March 20, 2024 |

Part III – Crunching Some Numbers – Researcher Shares His Outlook

In this section of this multi-part research article related to the potential economic destruction of the Covid-19 virus event across the global markets ( Part I , Part II ). We’re going to peer into data related to the GDP and other factors of the ...
Chris Vermeulen | March 17, 2020 |

From Cystic Fibrosis to COVID-19: A Medical Solution Like No Other

(Image via Dymedso Inc.) Airway clearance therapy has been a cornerstone of treatments aimed at minimizing the devastating effects of airway obstruction, infection, and inflammation caused by a buildup of mucus in lung conditions … but finding a non-invasive solutio...
Stockhouse Editorial | December 8, 2020 |

XPhyto: Proof of Concept for Mescalin Synthesis

It’s become a much talked-about story on both sides of the Atlantic. XPhyto Therapeutics Corp. ( CSE: XPHY ) (FSE: 4XT) (OTCQB: XPHYF) has earned considerable media coverage in recent months due to its expansion into the development of psychedelic d...
Marc Davis | June 9, 2021 |

Is this stunning 'evidence' that NervGen has the goods?

This could be the signal that tiny NervGen Pharma Corp. (TSX-V:NGEN; OTCQX:NGENF) is destined to be one of the top performing biotech startup stocks this year. It came in a seemingly innocuous podcast interview about the company’s ongoing Phase 1b/2...
Knox Henderson | February 1, 2024 |

Crunching Some Numbers – Our Researchers Share Their Data – Part II

Continuing our earlier multi-part research post related to our extensive number crunching and predictive modeling systems expectations going forward many years, (Part I ) this second part will highlight some existing data points and start to discuss the concepts of what t...
Chris Vermeulen | March 17, 2020 |

Invasive Species

Invasive species: Any kind of living organism—an amphibian (like the cane toad), plant, insect, fish, fungus, bacteria, or even an organism's seeds or eggs—that is not native to an ecosystem and causes harm. They can harm the environment, the economy, or even human he...
Streetwise Reports | August 14, 2019 |

Covid-19: Who, what, when, where and why

If there is one thing we know about the coronavirus, it’s that getting a jump on it helps to limit the number of infections. Clearly the best time to stop this, and all outbreaks, is in its early stages. Both China and the United States have been accused of...
Richard (Rick) Mills | April 13, 2020 |

SPY Breaks Below Fibonacci Bearish Trigger Level

Our research team wanted to share this chart with our friends and followers. This dramatic breakdown in price over the past 4+ days has resulted in a very clear bearish trigger which was confirmed by our Adaptive Fibonacci Price Modeling system. We believe this downside move...
Chris Vermeulen | February 26, 2020 |

Fibonacci Price Amplitude Arcs Predict Big Gold Breakout

Precious metals have become the focus of many researchers and traders recently. Bank of America recently raised its target to $3000 for gold (source: https://www.bloomberg.com ). In December 2019, we published a research article suggesting precious metals were setting up a ...
Chris Vermeulen | April 27, 2020 |
1 2 3 4 5 6 7 8 9 10 ...